Fred E Cohen Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.
Get free email notifications about insider trading for Fred E Cohen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Fred E Cohen. Fred E Cohen is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in GENOMIC HEALTH INC ($GHDX) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CareDx, Inc. ($CDNA) and Director in VERACYTE, INC. ($VCYT) and Director in TANDEM DIABETES CARE INC ($TNDM) and Director in Roka BioScience, Inc. ($ROKA) and Director in Progyny, Inc. ($PGNY) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in UroGen Pharma Ltd. ($URGN).
Fred E Cohen in FIVE PRIME THERAPEUTICS, INC.
Trading Symbol: FPRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Fred E Cohen: Director
Holdings: 24,807 shares
Current Value: $1,125,742
Latest Transaction: May 23 2016
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Fred E Cohen in FIVE PRIME THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, CDNA, FPRX, GHDX, NTLA, PGNY, ROKA, TNDM, URGN, VCYT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 12.70 | 12,500 | 158,750 | 0 | |
Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 7.26 | 4,065 | 29,512 | 0 | |
Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 5.54 | 4,065 | 22,520 | 0 | |
Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 8.49 | 4,065 | 34,512 | 0 | |
Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 12.70 | 12,500 | 158,750 | 24,807 | 12.3 K to 24.8 K (+101.57 %) |
Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 7.26 | 4,065 | 29,512 | 12,307 | 8.2 K to 12.3 K (+49.32 %) |
Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 5.54 | 4,065 | 22,520 | 8,242 | 4.2 K to 8.2 K (+97.32 %) |
Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 8.49 | 4,065 | 34,512 | 4,177 | 112 to 4.2 K (+3,629.46 %) |
Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 |
Page: 1